newsfilter
← Latest News
GlobeNewswire·

Collegium to Participate in Upcoming Investor Conferences

  • Collegium Pharmaceutical, Inc. (NASDAQ: COLL) will participate in the Morgan Stanley 24th Annual Global Healthcare Conference Fireside Chat on Tuesday, September 15, 2026, at 4:05 p.m. ET in New York, NY.
  • The company will present at the H.C. Wainwright 28th Annual Global Investment Conference on Wednesday, September 16, 2026, at 9:00 a.m. ET in New York, NY.
  • Live webcasts of these presentations will be accessible via the Investors section of the company's website, with replays archived for 90 days post-event.
  • Collegium focuses on formulation innovation for complex central nervous system & pain conditions, featuring a portfolio that includes JORNAY PM ® (methylphenidate HCl) & AZSTARYS ® (serdexmethylphenidate & dexmethylphenidate).
  • Investor contact is Ian Karp, Head of Investor Relations, while media inquiries should be directed to Jessica Cotrone, Senior Vice President, Corporate Communications & Corporate Affairs.